<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Market Chatter: Novo Nordisk's Wegovy Delivers Increased Weight Loss in Triple-Dose Trials</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Market Chatter: Novo Nordisk's Wegovy Delivers Increased Weight Loss in Triple-Dose Trials</h1>
  <ul>
<li>A Silver or Gold subscription plan is required to access premium news articles.</li>
<li>Market Chatter: Novo Nordisk's Wegovy Delivers Increased Weight Loss in Triple-Dose Trials Novo Nordisk's (NVO) obesity treatment drug Wegovy led to increased weight loss in patients during t Upgrade to read this MT News</li>
</ul>
<p><a href="https://finance.yahoo.com/news/market-chatter-novo-nordisk-apos-102608464.html">Source</a> · 2025-09-15T10:26:08+00:00</p>
</body>
</html>